Colleen A Hanlon1, Logan T Dowdle2, Thomas Naselaris3, Melanie Canterberry2, Bernadette M Cortese4. 1. Department of Psychiatry and Behavioral Sciences, MUSC, Charleston, SC 29425, United States; Department of Neurosciences, MUSC, Charleston, SC 29425, United States; Center for Biomedical Imaging, MUSC, Charleston SC 29425, United States. 2. Department of Psychiatry and Behavioral Sciences, MUSC, Charleston, SC 29425, United States. 3. Department of Neurosciences, MUSC, Charleston, SC 29425, United States; Center for Biomedical Imaging, MUSC, Charleston SC 29425, United States. 4. Department of Psychiatry and Behavioral Sciences, MUSC, Charleston, SC 29425, United States. Electronic address: corteseb@musc.edu.
Abstract
BACKGROUND: Although the visual cortex does not typically receive much attention in addiction literature, neuroimaging studies often report significant activity in visual areas when drug users are exposed to drug cues. The purpose of this meta-analysis was to investigate the frequency with which occipital cortex activity is observed during drug cue exposure and to determine its spatial distribution. METHODS: A comprehensive literature search was performed of human functional neuroimaging studies of drug cue-reactivity. Fifty-five studies were used to determine the frequency with which clusters of significant visual cortex activity during visual drug cues versus non-drug cues were reported. The spatial distribution of visual cortex activations was determined via activation likelihood estimation (ALE; FDR corrected, p<0.01) in a subset of these studies (n=24). RESULTS: Eighty-six percent of studies that reported fMRI results for drug versus neutral visual cues within a substance-dependent group showed significant drug-elicited activity in the visual cortex. ALE revealed clusters in the left secondary visual cortex (BA 19) and clusters in the primary visual cortex (BA 17) that were consistently activated by drug cues. CONCLUSIONS: These data demonstrate that the visual cortex, often overlooked in our discussions of the neural circuitry of addiction, consistently discriminates drug cues from neutral cues in substance dependent populations. While it remains unclear whether drug cue-elicited activation in occipital cortex is related to the rewarding properties of the drug and/or attentional mechanisms, these data support further exploration.
BACKGROUND: Although the visual cortex does not typically receive much attention in addiction literature, neuroimaging studies often report significant activity in visual areas when drug users are exposed to drug cues. The purpose of this meta-analysis was to investigate the frequency with which occipital cortex activity is observed during drug cue exposure and to determine its spatial distribution. METHODS: A comprehensive literature search was performed of human functional neuroimaging studies of drug cue-reactivity. Fifty-five studies were used to determine the frequency with which clusters of significant visual cortex activity during visual drug cues versus non-drug cues were reported. The spatial distribution of visual cortex activations was determined via activation likelihood estimation (ALE; FDR corrected, p<0.01) in a subset of these studies (n=24). RESULTS: Eighty-six percent of studies that reported fMRI results for drug versus neutral visual cues within a substance-dependent group showed significant drug-elicited activity in the visual cortex. ALE revealed clusters in the left secondary visual cortex (BA 19) and clusters in the primary visual cortex (BA 17) that were consistently activated by drug cues. CONCLUSIONS: These data demonstrate that the visual cortex, often overlooked in our discussions of the neural circuitry of addiction, consistently discriminates drug cues from neutral cues in substance dependent populations. While it remains unclear whether drug cue-elicited activation in occipital cortex is related to the rewarding properties of the drug and/or attentional mechanisms, these data support further exploration.
Authors: Andrew J Waters; Saul Shiffman; Michael A Sayette; Jean A Paty; Chad J Gwaltney; Mark H Balabanis Journal: Health Psychol Date: 2003-07 Impact factor: 4.267
Authors: Amy C Janes; Stacey Farmer; Alyssa L Peechatka; Blaise de B Frederick; Scott E Lukas Journal: Neuropsychopharmacology Date: 2015-01-08 Impact factor: 7.853
Authors: Bernadette M Cortese; Thomas W Uhde; Kathleen T Brady; F Joseph McClernon; Qing X Yang; Heather R Collins; Todd LeMatty; Karen J Hartwell Journal: Psychiatry Res Date: 2015-10-09 Impact factor: 3.222
Authors: Travis T Nichols; Jonathan Foulds; Jessica M Yingst; Susan Veldheer; Shari Hrabovsky; John Richie; Thomas Eissenberg; Stephen J Wilson Journal: Brain Res Bull Date: 2015-10-23 Impact factor: 4.077
Authors: Melanie A Blair; Jennifer L Stewart; April C May; Martina Reske; Susan F Tapert; Martin P Paulus Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2018-03-21
Authors: Joseph C Cheng; Joseph Secondary; William H Burke; J Paul Fedoroff; R Gregg Dwyer Journal: Curr Psychiatry Rep Date: 2015-07 Impact factor: 5.285
Authors: Zhenhao Shi; An-Li Wang; Victoria P Fairchild; Catherine A Aronowitz; Kevin G Lynch; James Loughead; Daniel D Langleben Journal: Tob Control Date: 2021-10-01 Impact factor: 7.552
Authors: Jessica P Y Hua; Thomas M Piasecki; Yoanna E McDowell; Cassandra L Boness; Constantine J Trela; Anne M Merrill; Kenneth J Sher; John G Kerns Journal: Drug Alcohol Depend Date: 2020-02-15 Impact factor: 4.492